Fill out my online form.
Brad A. Wong, President & CEO

At the Heart of PH Advocacy for Quality, Affordable Health Care and PH Research

As the heart of the pulmonary hypertension (PH) community, the Pulmonary Hypertension Association (PHA) advocates on behalf patients and caregivers while also empowering them with the resources necessary to actively champion for access to the treatment and care they need and deserve. Faced with new challenges and opportunities this year, PHA is escalating our efforts to both represent the community and ensure that our members have tools to help them make PH advocacy personal.
Read more

Traci BraxtonWE tv’s Braxton Family Values Reality Star Traci Braxton Teams with PHA for a Cause Close to Her Heart

National recording artist Traci Braxton, who stars alongside her family on the hit WE tv reality show, Braxton Family Values, has three very personal reasons for supporting the Pulmonary Hypertension Association (PHA) as a PHA celebrity champion. Her son and two of her sisters battle diseases that can be associated with pulmonary hypertension (PH), a life threatening, often misdiagnosed progressive lung disease. Read more >>

Rare Disease DayPulmonary Hypertension Association Rallies Community Ahead of Rare Disease Day

The PH community will join PHA on Feb. 28 to recognize Rare Disease Day. PHA’s goal is to make the voice of PH and many associated rare diseases heard. We will do this with a social media campaign led by many PHA support group members and other supporters. Learn how you can join us in this effort.

Trial resultsSERAPHIN Trial: Study Finds Macitentan Can Improve Quality of Life for Some PH Patients

Patients with WHO Group 1 PH (PAH, pulmonary arterial hypertension), a serious, progressive and often fatal lung disease, typically have a number of symptoms and limitations that affect the quality of everyday living. Depending on the severity of the disease, patients may experience negative physical, social, emotional and psychological impacts. Research has indicated that macitentan (Opsumit®), an endothelin receptor antagonist (ERA), might help improve the health-related quality of life (HRQoL) and reduce the risk of deterioration over time. Read more >>

Watch my Music Video - Breathless not Hopeless

PHANews logo 2015 PHA Classroom icon myPHA icon PHA Online University icon
The latest PH and PHA news and community events, on the web and delivered to your inbox each week.
Free educational resources for PH patients and families.
An online community for those living with PH to connect and share.
Earn CME/CE credits at PHA's educational website for healthcare professionals.

Patient-to-Patient Support Line: 1-800-748-7274

FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs. PHA does not endorse or recommend any commercial products or services.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Terms of Use    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2017 Pulmonary Hypertension Association. All Rights Reserved.

BBB Accredited Charity BEST in AmericaCharity Navigator

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.